The Readout Loud

324 Episodes

1. 222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment

   Published: 18/08/2022
2. 221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing

   Published: 11/08/2022
3. 220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble

   Published: 04/08/2022
4. 219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data

   Published: 28/07/2022
5. 218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search

   Published: 21/07/2022
6. 217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'

   Published: 14/07/2022
7. 216: VC malaise, FDA confusion, & yet another Alzheimer's debate

   Published: 07/07/2022
8. 215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines

   Published: 30/06/2022
9. 214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict

   Published: 23/06/2022
10. 213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback

    Published: 16/06/2022
11. 212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

    Published: 09/06/2022
12. 211: Biotech's catch-22, a $100 genome, & dealing with monkeypox

    Published: 02/06/2022
13. 210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

    Published: 26/05/2022
14. Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison

    Published: 19/05/2022
15. Episode 208: A CEO's arrest, Pfizer's big deal, & Covid on the rise

    Published: 12/05/2022
16. Episode 207: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner

    Published: 05/05/2022
17. Episode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum

    Published: 28/04/2022
18. Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices

    Published: 21/04/2022
19. Episode 204: Leana Wen on the pandemic's new normal and whether Twitter is real life

    Published: 14/04/2022
20. Episode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success

    Published: 07/04/2022